The US Deprescribing Research Network: a network to catalyze deprescribing science

Deprescribing plays a critical role in ensuring safe and effective healthcare for older adults, including but not limited to those with vulnerabilities such as multimorbidity and dementia, which increase the risk of harm from unnecessary medications. However, much is unknown on how to safely and effectively stop medications. In response, the US Deprescribing Research Network (USDeN) was created with a mission of enhancing the quality, volume, and real-world impact of research aimed at optimizing medication use among older adults. This Perspective explores the rationale for its creation, the principles and ideas that animate its work, its impacts on research, and future directions for deprescribing research. By advancing research in this area, we aim to improve healthcare outcomes and reduce medication-related harm among older adults.

Authors

Institutions

Publication Details

Journal
Frontiers in Medicine
Published
2025-07-16
DOI
https://doi.org/10.3389/fmed.2025.1622200
Primary Topic
Pharmaceutical Practices and Patient Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The US Deprescribing Research Network: a network to catalyze deprescribing science

Jonathan D. Norton, Michael Alan Steinman, Cynthia M. Boyd, Raha Shahroodi
Frontiers in Medicine
Pharmaceutical Practices and Patient Outcomes
article

The US Deprescribing Research Network: a network to catalyze deprescribing science

Jonathan D. Norton, Michael Alan Steinman, Cynthia M. Boyd, Raha Shahroodi
article en

Abstract

Deprescribing plays a critical role in ensuring safe and effective healthcare for older adults, including but not limited to those with vulnerabilities such as multimorbidity and dementia, which increase the risk of harm from unnecessary medications. However, much is unknown on how to safely and effectively stop medications. In response, the US Deprescribing Research Network (USDeN) was created with a mission of enhancing the quality, volume, and real-world impact of research aimed at optimizing medication use among older adults. This Perspective explores the rationale for its creation, the principles and ideas that animate its work, its impacts on research, and future directions for deprescribing research. By advancing research in this area, we aim to improve healthcare outcomes and reduce medication-related harm among older adults.

Frontiers in MedicineVol. 12
San Francisco VA Medical Center (US), Johns Hopkins University (US), Johns Hopkins Medicine (US), University of California San Francisco Medical Center (US)
Openalex Percentile: Top 80%
Pharmaceutical Practices and Patient Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The US Deprescribing Research Network: a network to catalyze deprescribing science — Jonathan D. Norton, Michael Alan Steinman, et al. · Frontiers in Medicine (2025) | TGRS Research Map | TGRS